In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Cytek BioSciences Inc (NASDAQ: CTKB) closed at $3.37 in the last session, up 3.69% from day before closing price of $3.25. In other words, the price has increased by $3.69 from its previous closing price. On the day, 0.76 million shares were traded. CTKB stock price reached its highest trading level at $3.435 during the session, while it also had its lowest trading level at $3.2601.
Ratios:
We take a closer look at CTKB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.40. For the most recent quarter (mrq), Quick Ratio is recorded 4.95 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
On January 31, 2025, Goldman Downgraded its rating to Sell which previously was Buy and also lowered its target price recommendation from $7 to $4.50.
On December 14, 2023, Stephens started tracking the stock assigning a Overweight rating and target price of $9.Stephens initiated its Overweight rating on December 14, 2023, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when McCombe William D. bought 35,000 shares for $2.78 per share. The transaction valued at 97,300 led to the insider holds 55,746 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTKB now has a Market Capitalization of 426840800 and an Enterprise Value of 177125488. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 1.13. Its current Enterprise Value per Revenue stands at 0.899 whereas that against EBITDA is -8.867.
Stock Price History:
The Beta on a monthly basis for CTKB is 1.33, which has changed by -0.48153847 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, CTKB has reached a high of $7.63, while it has fallen to a 52-week low of $2.37. The 50-Day Moving Average of the stock is 7.28%, while the 200-Day Moving Average is calculated to be -28.48%.
Shares Statistics:
According to the various share statistics, CTKB traded on average about 1.17M shares per day over the past 3-months and 738030 shares per day over the past 10 days. A total of 127.60M shares are outstanding, with a floating share count of 114.61M. Insiders hold about 9.52% of the company’s shares, while institutions hold 60.99% stake in the company. Shares short for CTKB as of 1751241600 were 4741336 with a Short Ratio of 4.06, compared to 1748563200 on 5408863. Therefore, it implies a Short% of Shares Outstanding of 4741336 and a Short% of Float of 4.8800003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
